What's new
- お知らせ私たちについて 背景・経緯ページを更新しました
- 論文・発表
- J Infect Chemother. 2024 Mar 1:S1341-321X(24)00069-2. doi: 10.1016/j.jiac.2024.02.028. Epub ahead of print. PMID: 38431219.
Determination of intracellular tenofovir-diphosphate and emtricitabine-triphosphate concentrations in dried blood spots for pre-exposure prophylaxis adherence.Tsuchiya K, Hayashi Y, Ryu S, Tran HT, Takano M, Tanaka K, Mizushima D, Oka S, Gatanaga H, Hamada A. - 論文・発表
- AIDS Res Hum Retroviruses. 2024 May 3. doi: 10.1089/AID.2024.0022. Epub ahead of print. PMID: 38666693.
Identification of New Circulating Recombinant Form of HIV-1 CRF127_07109 in Northern Vietnam.Hayashida T, Tran LK, Dang AL, Nagai M, Matsumoto S, Le HN, Van TD, Tran GV, Tanuma J, Pham TN, Oka S. - 論文・発表
- Glob Health Med. 2024 Apr 30;6(2):117-123. doi: 10.35772/ghm.2023.01112. PMID: 38690128; PMCID: PMC11043122..
Prevalence of transmitted drug resistance and phylogenetic analysis of HIV-1 among antiretroviral therapy-naïve patients in Northern Vietnam from 2019 to 2022.Tran GV, Hayashida T, Dang AL, Nagai M, Matsumoto S, Tran LK, Le HN, Van TD, Tanuma J, Pham TN, Oka S - 論文・発表
- Glob Health Med. 2023 Aug 31;5(4):216-222. doi: 10.35772/ghm.2023.01060. PMID: 37655187; PMCID: PMC10461328..
Steady-state pharmacokinetics of plasma tenofovir alafenamide (TAF), tenofovir (TFV) and emtricitabine (FTC), and intracellular TFV-diphosphate and FTC-triphosphate in HIV-1 infected old Japanese patients treated with bictegravir/FTC/TAF.Tran HT, Tsuchiya K, Kawashima A, Watanabe K, Hayashi Y, Ryu S, Hamada A, Gatanaga H, Oka S.
